What is the PrecivityAD2™ blood test?
PrecivityAD2™ is a blood test designed for individuals aged 55 and older exhibiting signs of mild cognitive impairment, aiding in the diagnosis of Alzheimer’s disease. The outcomes of the PrecivityAD2™ test, used alongside other diagnostic tools, assist your GP or specialist in confirming the diagnosis and formulating a treatment plan for Alzheimer’s disease.
The test involves a straightforward blood collection process. PrecivityAD2™ testing is only available at selected collection centres, for locations, please see the list below.
While no test can diagnose Alzheimer’s disease with absolute certainty, PrecivityAD2™ offers a less time consuming, more accessible, and minimally invasive alternative to traditional methods like amyloid PET scans and Cerebrospinal Fluid (CSF) testing.
.svg)
.svg)
.svg)
.svg)
